Skip to main content
Journal for Immunotherapy of Cancer logoLink to Journal for Immunotherapy of Cancer
. 2021 Jun 16;9(6):e002277corr1. doi: 10.1136/jitc-2020-002277corr1

Correction: Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score

PMCID: PMC8211064  PMID: 34135105

Dettorre GM, Dolly S, Loizidou A, On behalf of OnCovid study group et al. Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score. J Immunother Cancer 2021;9:e002277. doi: 10.1136/jitc-2020-002277

This paper has been updated to amend author affiliations.


Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group

RESOURCES